Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Can Assoc Radiol J ; 66(1): 71-8, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25623011

RESUMO

During the past decade, cardiac magnetic resonance has gained increasing popularity in the diagnosis of hypertrophic cardiomyopathy because of its greater accuracy and better characterization of cardiac morphology compared with other imaging modalities. In this pictorial essay, a global clinical portrait of hypertrophic cardiomyopathy will be drawn. The various radiologic findings associated with each variant of hypertrophic cardiomyopathy, and the clinical edge offered by cardiac magnetic resonance will be discussed.


Assuntos
Hipertrofia Ventricular Esquerda/diagnóstico , Imageamento por Ressonância Magnética , Diagnóstico Diferencial , Ecocardiografia , Gadolínio , Humanos , Hipertrofia Ventricular Esquerda/classificação , Hipertrofia Ventricular Esquerda/fisiopatologia , Hipertrofia Ventricular Esquerda/terapia , Imageamento por Ressonância Magnética/métodos
2.
Int J Technol Assess Health Care ; 24(4): 473-80, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18828943

RESUMO

OBJECTIVES: Although increasing effort is being devoted to developing strategies to increase knowledge transfer and the uptake of health technology assessment (HTA) by various stakeholders, very little is known about the utilization and dissemination of HTA findings by patient and consumer organizations. The goal of this study is to understand how and why patient and consumer organizations use HTA findings within their organizations, and what factors influence how and when they communicate their findings to members or other organizations. METHODS: We examined the use and dissemination of four controversial HTA reports by sixteen patient and consumer organizations in Ontario and Quebec. We gathered data from semistructured interviews conducted between December 2006 and April 2007. RESULTS: Although HTA findings are often used by the patient and consumer organizations, key differences were observed in exactly how the four HTA reports were used. Three types of use (instrumental, conceptual, and symbolic) are reported and illustrated. We highlight the importance of the organization's mission and knowledge base in explaining the types of use observed. CONCLUSIONS: We contend that the use and dissemination of HTA reports by specific groups could help in widening the debate around controversial health technologies. The implications and opportunities for HTA agencies relate to the following: (i) identification of "lay" organizations that could help in disseminating results; (ii) acknowledgement of a "lay" audience for HTA findings; (iii) strategic inclusion of advocacy groups during the assessment process for highly controversial technologies; and (iv) contribution of these organizations to the push efforts of knowledge transfer.


Assuntos
Participação da Comunidade , Informação de Saúde ao Consumidor/métodos , Disseminação de Informação , Avaliação da Tecnologia Biomédica/organização & administração , Uso de Medicamentos , Eletroconvulsoterapia/métodos , Humanos , Seguro de Serviços Farmacêuticos/estatística & dados numéricos , Participação do Paciente , Cuidado Pré-Natal/métodos , Antígeno Prostático Específico/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA